Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$27,000.00
Evaluating the Effects of Contemporary Clinical Practice Changes on Durable Left Ventricular Assist Device Outcomes
EF 2024-25
Résumé
Left ventricular assist devices (LVAD) support patients with advanced heart failure, a leading cause of mortality in Canada. Despite their increasing use in modern practice, the clinical management of LVADs is variable, with limited consensus on optimal anticoagulation strategies to reduce nonsurgical bleeding, guideline-directed medical therapy (GDMT) regimens to manage in-hospital and long-term outcomes, and the value of INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support) profiling (1-7 severity scale) in long-term risk stratification. This study aims to address these gaps by evaluating whether (i) limited use of intravenous heparin reduces nonsurgical bleeding, (ii) specific GDMT optimization prevents vasoplegia during LVAD implantation, and (iii) INTERMACS profiling aids prognostication for destination therapy LVADs. We hypothesize that these strategies have improved LVAD outcomes at our center. This study includes a retrospective review of all LVAD patients at Toronto General Hospital (2006-2024) and prospective data collection during the funding period. Patients will be stratified by anticoagulation strategy, GDMT regimen, and INTERMACS profile. The primary outcome is all-cause mortality; secondary outcomes are major adverse cardiovascular events, bleeding complications and intraoperative vasoplegia. Statistical methods include comparative survival analyses, predictive modelling, and relative risk assessments. Notably, this study coincides with the relaunch of IMACS (International Registry for Mechanically Assisted Circulatory Support), providing a unique opportunity to benchmark Canadian LVAD outcomes internationally and generate high-powered data to inform medical practices that help standardize and improve national LVAD care.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
530074
Name
Izumi Aliya
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Evaluating the Effects of Contemporary Clinical Practice Changes on Durable Left Ventricular Assist Device Outcomes
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Anticoagulation; Cardiac Surgery; Cardiology; Durable Mechanical Circulatory Support; Guideline-Directed Medical Therapy; Heart Failure; Imacs Registry; Intermacs Profile; Left Ventricular Assist Device
Abstract
Left ventricular assist devices (LVAD) support patients with advanced heart failure, a leading cause of mortality in Canada. Despite their increasing use in modern practice, the clinical management of LVADs is variable, with limited consensus on optimal anticoagulation strategies to reduce nonsurgical bleeding, guideline-directed medical therapy (GDMT) regimens to manage in-hospital and long-term outcomes, and the value of INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support) profiling (1-7 severity scale) in long-term risk stratification. This study aims to address these gaps by evaluating whether (i) limited use of intravenous heparin reduces nonsurgical bleeding, (ii) specific GDMT optimization prevents vasoplegia during LVAD implantation, and (iii) INTERMACS profiling aids prognostication for destination therapy LVADs. We hypothesize that these strategies have improved LVAD outcomes at our center. This study includes a retrospective review of all LVAD patients at Toronto General Hospital (2006-2024) and prospective data collection during the funding period. Patients will be stratified by anticoagulation strategy, GDMT regimen, and INTERMACS profile. The primary outcome is all-cause mortality; secondary outcomes are major adverse cardiovascular events, bleeding complications and intraoperative vasoplegia. Statistical methods include comparative survival analyses, predictive modelling, and relative risk assessments. Notably, this study coincides with the relaunch of IMACS (International Registry for Mechanically Assisted Circulatory Support), providing a unique opportunity to benchmark Canadian LVAD outcomes internationally and generate high-powered data to inform medical practices that help standardize and improve national LVAD care.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Izumi, Aliya
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~